It’s all a bit hard I think for we non biotechnician patent lawyers to get a happy one line summary out of a zillion overlapping quite complex patents. ATM had Simpson Grierson review the patent suite and they provided a positive review.
Perhaps though Harrie, if it is a concern for you, you may wish to ask at the AGM in November if there are any commercial implications, that might provide you and perhaps the general media also with a better public statement than just ‘the first one expires in 2016’.
NBT, do consider that the a2 milk company operate within the premium milk market, the products are value added irrespective of patents, similar to soy milk or lactose free milk.